Top 50 most cited articles on prostatic artery embolization for benign prostatic hyperplasia: A bibliometric review

Prostate artery embolization is a well-known and promising treatment for benign prostatic hyperplasia, with the quantum leaps of research in medicine.We aim to provide an up-to-date review of the novel technique, including large retrospective studies and randomized control trials, ends with discussions of advantages and disadvantages of this minimally invasive technique.Benign prostatic hyperplasia (BPH) is a common disease in middleaged and elderly men, with an incidence of >50% in those aged over 50 years and >90% in those aged over 80 years. 1 BPH often induces lower urinary tract symptoms (LUTS) such as bladder outlet obstruction and dysuria, which further damage the bladder and kidneys.Symptomatic BPH can seriously affect patient health and quality of life. 2 Current common treatments for BPH include drug therapy, open prostatectomy, and transurethral resection of the prostate (TURP), but each has certain limitations.Prostatic artery embolization (PAE) is a novel minimally invasive treatment for BPH with the advantages of high safety, minor trauma, short hospital stay, and repeatability and has become a hot research topic in recent years.